156 related articles for article (PubMed ID: 6667621)
21. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
Goh TH; Ang ES; Yip YC
J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
[TBL] [Abstract][Full Text] [Related]
22. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
23. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
[TBL] [Abstract][Full Text] [Related]
24. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
Pizarro E; Gomez-Rogers C; Rowe PJ
Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
[TBL] [Abstract][Full Text] [Related]
26. Iron deficiency in women using modern copper intrauterine devices.
Kivijärvi A; Timonen H; Rajamäki A; Grönroos M
Obstet Gynecol; 1986 Jan; 67(1):95-8. PubMed ID: 3940345
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomized comparative trial of the Gravigard, Latex Leaf, Dalkon Shield and Multiload Cu 250 IUDs.
McCarthy TG; Chew SC; Lim SM; Cheng MC; Ratnam SS
Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):228-32. PubMed ID: 3545173
[TBL] [Abstract][Full Text] [Related]
28. Menstrual pattern changes following laparoscopic sterilization with different occlusion techniques: a review of 10,004 cases.
Bhiwandiwala PP; Mumford SD; Feldblum PJ
Am J Obstet Gynecol; 1983 Mar; 145(6):684-94. PubMed ID: 6219585
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
30. Corpus luteum function in lactating women using the Progestasert system.
Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
[TBL] [Abstract][Full Text] [Related]
31. Thyroid function in lactating women using the Progestasert system.
Ibrahim II; Abdalla MI; Badraoui MH; Abdelaal AE
Contracept Deliv Syst; 1981 Apr; 2(1):139-44. PubMed ID: 12336866
[TBL] [Abstract][Full Text] [Related]
32. Ferritin, a faithful reflection of iron deficiency in IUD wearers with mild vaginal spotting.
Blum M; Ariel J; Zacharowitch D
Adv Contracept; 1991 Mar; 7(1):39-42. PubMed ID: 1872195
[TBL] [Abstract][Full Text] [Related]
33. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
34. A clinical study comparing the performance of three IUCDs (Multiload Copper 250, Copper T 200, and Lippes Loop C).
Fakhr MM; Fakhr DM; Hassan AA; Nasser NM
Popul Sci; 1988; 8():39-53. PubMed ID: 12316112
[TBL] [Abstract][Full Text] [Related]
35. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
Malmqvist R; Petersohn L; Bengtsson LP
Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
[TBL] [Abstract][Full Text] [Related]
36. Serum-prolactin levels in lactating women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
[TBL] [Abstract][Full Text] [Related]
37. Menstrual blood loss in IUD users: comparative study of eleven different IUDs in Mexican women.
Pedron N
Adv Contracept Deliv Syst; 1995; 11(3-4):245-53. PubMed ID: 12290877
[TBL] [Abstract][Full Text] [Related]
38. Serum and endometrial copper, zinc, iron and cobalt with inert and copper-containing IUCDs.
Fahmy K; Ghoneim M; Eisa I; el-Gazar A; Afifi A
Contraception; 1993 May; 47(5):483-90. PubMed ID: 8513675
[TBL] [Abstract][Full Text] [Related]
39. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
40. Patterns of copper loss--a comparison of the multiload Cu250, TCu-220C and Cu7 IUDs.
Goh TH; Tong SL
Contraception; 1986 Apr; 33(4):411-20. PubMed ID: 3731778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
